A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.
about
A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
A Phase I/biomarker study of b ...... ts with advanced solid tumors.
@en
A Phase I/biomarker study of b ...... ts with advanced solid tumors.
@nl
type
label
A Phase I/biomarker study of b ...... ts with advanced solid tumors.
@en
A Phase I/biomarker study of b ...... ts with advanced solid tumors.
@nl
prefLabel
A Phase I/biomarker study of b ...... ts with advanced solid tumors.
@en
A Phase I/biomarker study of b ...... ts with advanced solid tumors.
@nl
P2093
P2860
P1476
A Phase I/biomarker study of b ...... nts with advanced solid tumors
@en
P2093
Andrew B Nixon
Andrew Dellinger
Herbert I Hurwitz
Hope E Uronis
Jingquan Jia
Johanna C Bendell
Leigh Howard
Mark D Starr
Neal A Ready
Paula H Lee
P2860
P2888
P304
P356
10.1007/S00280-014-2647-X
P50
P577
2014-12-20T00:00:00Z